Nanocarriers in Veterinary Medicine: A Challenge for Improving Osteosarcoma Conventional Treatments

Simona Sapino, Giulia Chindamo, Daniela Chirio, Silvia Morel, Elena Peira, Cristina Vercelli, Marina Gallarate

Risultato della ricerca: Contributo su rivistaArticolo di reviewpeer review

Abstract

In recent years, several nanocarrier-based drug delivery systems, such as polymeric nanoparticles, solid lipid nanoparticles, metallic nanoparticles, liposomes, and others, have been explored to target and treat a wide variety of diseases. Their employment has brought many benefits, not only to human medicine but also to veterinary medicine, albeit at a slower rate. Soon, the use of nanocarriers could revolutionize the animal health sector, and many veterinary therapies will be more effective as a result. The purpose of this review is to offer an overview of the main applications of nanocarriers in the veterinary field, from supplements for animal health and reproduction to nanovaccines and nanotherapies. Among the major pathologies that can affect animals, special attention is given to canine osteosarcoma (OSA): a comparison with human OSA is provided and the main treatment options are reviewed emphasizing the benefits that nanocarriers could bring in the treatment of this widespread disease.

Lingua originaleInglese
Numero di articolo4501
RivistaNanomaterials
Volume12
Numero di pubblicazione24
DOI
Stato di pubblicazionePubblicato - dic 2022

Fingerprint

Entra nei temi di ricerca di 'Nanocarriers in Veterinary Medicine: A Challenge for Improving Osteosarcoma Conventional Treatments'. Insieme formano una fingerprint unica.

Cita questo